About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Philadelphia | 20,904 Studies Near You | Clareo Health

Clinical Trials LocationsPhiladelphia

Clinical Trials in Philadelphia

Discover 20,904 clinical trials near Philadelphia, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 15621-15640 of 20,904 trials

COMPLETEDPhase 4< 1 mile

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

NCT00434213

This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.

Attention Deficit Hyperactivity Disorder

Noven Therapeutics309 participantsStarted Jan 2007

Scottsdale, Arizona, United States • Irvine, California, United States • San Marcos, California, United States +26 more locations

COMPLETEDPhase 3< 1 mile

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

NCT00499863

To assess the efficacy and safety of efficacy of MTS compared to placebo

Noven Therapeutics217 participantsStarted Jul 2007

Scottsdale, Arizona, United States • Lafayette, California, United States • Wildomar, California, United States +29 more locations

Find Trials by Condition in Philadelphia

Breast Cancerin Philadelphia Lung Cancerin Philadelphia Prostate Cancerin Philadelphia Colorectal Cancerin Philadelphia Melanomain Philadelphia Leukemiain Philadelphia Lymphomain Philadelphia Pancreatic Cancerin Philadelphia Ovarian Cancerin Philadelphia Brain Cancerin Philadelphia

Data from ClinicalTrials.govTerms

COMPLETED< 1 mile

Pharmacokinetics of Ampicillin in Neonates With Moderate to Severe Hypoxic-Ischemic Encephalopathy

NCT03129620

Controlled Hypothermia has become the standard of care for neonates with moderate to severe HIE. Ampicillin and aminoglycosides are drugs that are universally used for the treatment of suspected neonatal sepsis, which may or may not be responsible for the etiology of HIE. Currently, medication dosage regimens are not altered in the setting of CH. A better understanding of the effects of our interventions on this unique population may help us tailor our therapy to the specific circumstances of the patient

Drexel University14 participantsStarted Mar 2013

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 36.6 miles

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

NCT00489411

RATIONALE: Duloxetine may lessen peripheral neuropathy caused by chemotherapy. It is not yet known whether duloxetine is more effective than a placebo in treating peripheral neuropathy caused by chemotherapy. PURPOSE: This randomized phase III trial is studying duloxetine to see how well it works compared with a placebo in treating peripheral neuropathy caused by chemotherapy in patients with cancer.

NeurotoxicityPainPeripheral Neuropathy+1 more

Alliance for Clinical Trials in Oncology231 participantsStarted Apr 2008

Antioch, California, United States • Berkeley, California, United States • Burlingame, California, United States +472 more locations

COMPLETEDPhase 410 miles

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

NCT01232491

This trial is conducted in Europe, and North and South America. The aim of this trial is to investigate if a dietary intervention has an effect on weight when initiating insulin treatment in subjects with type 2 diabetes currently treated with oral antidiabetic drugs (OADs).

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S611 participantsStarted Oct 2010

Birmingham, Alabama, United States • Ozark, Alabama, United States • Anaheim, California, United States +109 more locations

COMPLETEDPhase 313 miles

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

NCT00829829

The purpose of this clinical research study was to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning allopurinol treatment for gout. Subjects will participate in this study for approximately 22 weeks. Rilonacept is being studied for use in preventing allopurinol-induced gout flares.

Intercritical Gout

Regeneron Pharmaceuticals241 participantsStarted Feb 2009

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Peoria, Arizona, United States +88 more locations

COMPLETEDPhase 329 miles

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

NCT01644331

The primary objective of this study is to compare the effects of oral Tolvaptan vs. placebo as an adjunct to fixed dose IV furosemide on dyspnea relief in patients with acute decompensated heart failure The primary hypothesis is that the addition of oral Tolvaptan to fixed dose furosemide will be more effective at relieving dyspnea than fixed dose furosemide alone

Heart FailureDyspnea

Duke University257 participantsStarted Oct 2012

Aurora, Colorado, United States • Atlanta, Georgia, United States • Gainesville, Georgia, United States +15 more locations

COMPLETED38 miles

Study of Autoimmune Disease Complications Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases

NCT02739386

The research questions to be addressed by this study are as follows: 1. What is the prevalence of ipilimumab use among adults with a history of autoimmune disease that received treatment with ipilimumab for advanced melanoma? 2. Do melanoma patients with a history of autoimmune disease experience complications that require hospitalization related to their underlying autoimmune disease following treatment with ipilimumab?

Bristol-Myers Squibb370 participantsStarted Feb 2016

Princeton, New Jersey, United States

COMPLETED38 miles

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

NCT01950650

This study is conducted in Asia, Europe and in the United States of America. The aim of this study is to examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Novo Nordisk A/S1,800 participantsStarted Mar 2010

Princeton, New Jersey, United States • Beijing, Beijing Municipality, China • Paris La Défense Cedex, France +7 more locations

COMPLETED38 miles

Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event

NCT00785044

The study was designed to study the utility of meta-iodobenzylguanidine (123I-mIBG) imaging to identify those participants with heart failure who would experience an adverse cardiac event during 24 months of follow-up from the administration date of 123I-mIBG in previous studies MBG311 or MBG312.

Congestive Heart Failure

GE Healthcare471 participantsStarted May 2008

Princeton, New Jersey, United States

COMPLETEDPhase 249 miles

Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares

NCT00610363

This was a clinical research study to determine the safety and effectiveness of an experimental drug called rilonacept in participants with gout who were beginning another additional treatment. Participants participated in this study for approximately 24 weeks. Rilonacept was being studied for use in preventing gout attacks in participants who had gout.

Regeneron Pharmaceuticals83 participantsStarted Nov 2007

San Diego, California, United States • Santa Maria, California, United States • Whittier, California, United States +31 more locations

COMPLETEDNA55 miles

Human Phototoxicity Test

NCT02754102

To determine the phototoxic potential of a topically applied article in human subjects.

Sunscreening Agents

Bayer35 participantsStarted May 2016

Piscataway, New Jersey, United States

COMPLETEDPhase 261 miles

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

NCT01393626

This study investigates safety and efficacy of CP-690,550 in adult patients with moderate to severe Crohn's disease. The study hypothesis is that at least one dose of the tested drug is more effective than placebo (inactive drug).

Crohn's Disease

Pfizer280 participantsStarted Oct 2011

Anaheim, California, United States • Anaheim, California, United States • Anaheim, California, United States +137 more locations

COMPLETEDPhase 281 miles

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

NCT00530816

To evaluate the best overall response rate, safety and tolerability of carfilzomib in patients with relapsed or refractory multiple myeloma.

Multiple Myeloma

Amgen164 participantsStarted Sep 2007

Scottsdale, Arizona, United States • Beverly Hills, California, United States • Laguna Hills, California, United States +27 more locations

COMPLETEDPhase 281 miles

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

NCT00094172

Patients who have been diagnosed with clinically isolated syndrome (CIS) often develop problems related to the central nervous system, which controls the nerves in the body. Some of these patients may later be diagnosed with multiple sclerosis (MS), a progressive disease of the nervous system. The purpose of this study is to determine if the drug atorvastatin is helpful to CIS patients. Study hypothesis: Early intervention with atorvastatin in patients with CIS will result in a state of immunological tolerance.

Multiple Sclerosis

National Institute of Allergy and Infectious Diseases (NIAID)82 participantsStarted May 2005

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +11 more locations

WITHDRAWNPhase 281 miles

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

NCT02511613

The purpose of this study is to evaluate anatomical and functional effect of combination therapy of Squalamine Lactate Ophthalmic Solution, 0.2% administered twice daily with monthly ranibizumab intravitreal injections in patients with choroidal neovascularization due to AMD.

Age-Related Macular Degeneration

Ohr Pharmaceutical Inc.Started Jul 2015

Beverly Hills, California, United States • Hagerstown, Maryland, United States • New York, New York, United States +1 more locations

COMPLETEDPhase 187 miles

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

NCT01635712

Hsp90 is a chemical in the body that is involved int he promotion of cancer. SNX-5422 is an experimental drug that blocks Hsp90.

Esanex Inc.10 participantsStarted Feb 2014

Sacramento, California, United States • Augusta, Georgia, United States • Hackensack, New Jersey, United States +2 more locations

COMPLETEDPhase 195 miles

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

NCT01949532

The purpose of this study is to see how the body and the cancer react to carfilzomib, including measuring the amount of the study drug in the blood at certain times following dosing. This study is being done in people with normal kidney function and those with end-stage renal disease to see if they respond differently to the study drug.

Relapsed Multiple MyelomaEnd-stage Renal Disease

Amgen26 participantsStarted Jan 2014

Detroit, Michigan, United States • Lake Success, New York, United States • Canton, Ohio, United States +10 more locations

COMPLETEDPhase 1/2269 miles

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

NCT02309385

The purpose of this study is to determine the efficacy, safety, and tolerability of dexamethasone sodium phosphate Visulex (DSP-Visulex) after repeated-dose administration in patients with acute anterior uveitis.

Non-Infectious Anterior Uveitis

Aciont Inc44 participantsStarted Oct 2014

Cambridge, Massachusetts, United States • Charlotte, North Carolina, United States • Fargo, North Dakota, United States +3 more locations

TERMINATED271 miles

Discovery Elbow Long-Term Survivorship

NCT01308463

The Discovery™ Elbow Multi-Center Prospective Study (5-year Study) patients will be consented at the two year or next scheduled follow-up period for the early-enrolled patients.

SurvivorshipPain

Zimmer Biomet29 participantsStarted Jan 2011

Tampa, Florida, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +1 more locations

PreviousPage 782 of 1046Next

Diabetes

in Philadelphia

Heart Diseasein Philadelphia